Literature DB >> 17724438

Late death after unrelated-BMT for dyskeratosis congenita following conditioning with alemtuzumab, fludarabine and melphalan.

K Amarasinghe, C Dalley, I Dokal, A Laurie, V Gupta, J Marsh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17724438     DOI： 10.1038/sj.bmt.1705839

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  10 in total

1.  Revertant somatic mosaicism by mitotic recombination in dyskeratosis congenita.

Authors:  Marjolijn C J Jongmans; Eugene T P Verwiel; Yvonne Heijdra; Tom Vulliamy; Eveline J Kamping; Jayne Y Hehir-Kwa; Ernie M H F Bongers; Rolph Pfundt; Liesbeth van Emst; Frank N van Leeuwen; Koen L I van Gassen; Ad Geurts van Kessel; Inderjeet Dokal; Nicoline Hoogerbrugge; Marjolijn J L Ligtenberg; Roland P Kuiper
Journal:  Am J Hum Genet       Date:  2012-02-16       Impact factor: 11.025

2.  Lung transplantation for pulmonary fibrosis in dyskeratosis congenita: Case Report and systematic literature review.

Authors:  Neelam Giri; Rees Lee; Albert Faro; Charles B Huddleston; Frances V White; Blanche P Alter; Sharon A Savage
Journal:  BMC Blood Disord       Date:  2011-06-15

Review 3.  Bone marrow failure and the telomeropathies.

Authors:  Danielle M Townsley; Bogdan Dumitriu; Neal S Young
Journal:  Blood       Date:  2014-09-18       Impact factor: 22.113

Review 4.  Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.

Authors:  Jean-Hugues Dalle; Régis Peffault de Latour
Journal:  Int J Hematol       Date:  2016-02-12       Impact factor: 2.490

Review 5.  Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.

Authors:  R Peffault de Latour; C Peters; B Gibson; B Strahm; A Lankester; C D de Heredia; D Longoni; F Fioredda; F Locatelli; I Yaniv; J Wachowiak; J Donadieu; A Lawitschka; M Bierings; M Wlodarski; S Corbacioglu; S Bonanomi; S Samarasinghe; T Leblanc; C Dufour; J-H Dalle
Journal:  Bone Marrow Transplant       Date:  2015-06-08       Impact factor: 5.483

Review 6.  Inherited bone marrow failure syndromes in adolescents and young adults.

Authors:  David B Wilson; Daniel C Link; Philip J Mason; Monica Bessler
Journal:  Ann Med       Date:  2014-06-03       Impact factor: 4.709

7.  A Reduced-Intensity Conditioning Regimen for Patients with Dyskeratosis Congenita Undergoing Hematopoietic Stem Cell Transplantation.

Authors:  Adam S Nelson; Rebecca A Marsh; Kasiani C Myers; Stella M Davies; Sonata Jodele; Tracey A O'Brien; Parinda A Mehta
Journal:  Biol Blood Marrow Transplant       Date:  2016-02-01       Impact factor: 5.742

8.  Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita.

Authors:  A C Dietz; P J Orchard; K S Baker; R H Giller; S A Savage; B P Alter; J Tolar
Journal:  Bone Marrow Transplant       Date:  2010-04-12       Impact factor: 5.174

9.  Fatal Hemorrhagic Gastrointestinal Angioectasia after Bone Marrow Transplantation for Dyskeratosis Congenita.

Authors:  Jin Imai; Takayoshi Suzuki; Marie Yoshikawa; Makiko Dekiden; Hirohiko Nakae; Fumio Nakahara; Shingo Tsuda; Hajime Mizukami; Jun Koike; Muneki Igarashi; Hiromasa Yabe; Tetsuya Mine
Journal:  Intern Med       Date:  2016-12-01       Impact factor: 1.271

10.  A novel autosomal recessive TERT T1129P mutation in a dyskeratosis congenita family leads to cellular senescence and loss of CD34+ hematopoietic stem cells not reversible by mTOR-inhibition.

Authors:  Clemens Stockklausner; Simon Raffel; Julia Klermund; Obul Reddy Bandapalli; Fabian Beier; Tim H Brümmendorf; Friederike Bürger; Sven W Sauer; Georg F Hoffmann; Holger Lorenz; Laura Tagliaferri; Daniel Nowak; Wolf-Karsten Hofmann; Rebecca Buergermeister; Carolin Kerber; Tobias Rausch; Jan O Korbel; Brian Luke; Andreas Trumpp; Andreas E Kulozik
Journal:  Aging (Albany NY)       Date:  2015-11       Impact factor: 5.682
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.